Amgen (AMGN) Revenue (2009 - 2026)
Amgen (AMGN) posted quarterly Revenue of $8.6 billion for Q1 2026, up 5.76% year-over-year from $8.1 billion in Q1 2025, and down 12.65% quarter-over-quarter from $9.9 billion in Q4 2025.
Amgen (AMGN) Revenue (2009 - 2026) Analysis & Trends
Amgen's Revenue history runs 18 years deep, the most recent figure standing at $8.6 billion for Q1 2026.
- In Q1 2026, Revenue rose 5.76% year-over-year to $8.6 billion; the TTM figure through Mar 2026 stood at $37.2 billion (up 9.07% YoY), while the FY2025 annual figure was $36.8 billion, up 9.95% from the prior year.
- Revenue for Q1 2026 stood at $8.6 billion, down from $9.9 billion in the prior quarter.
- The five-year high for Revenue was $9.9 billion in Q4 2025, with the low at $459.0 million in Q4 2022.
- The 5-year median for Revenue is $8.1 billion (2025), against an average of $7.5 billion.
- The sharpest annual moves came in 2022 and 2023: Revenue plunged 93.3% in 2022, then jumped 1685.62% in 2023.
- Amgen's Revenue stood at $459.0 million in 2022, then surged by 1685.62% to $8.2 billion in 2023, then advanced by 10.86% to $9.1 billion in 2024, then advanced by 8.58% to $9.9 billion in 2025, then slipped by 12.65% to $8.6 billion in 2026.
- Business Quant data shows AMGN's Revenue at $8.6 billion in Q1 2026, $9.9 billion in Q4 2025, and $9.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 13.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.05 Bn |
| Mar 31, 2026 | 8.62 Bn |
| Dec 31, 2025 | 9.87 Bn |
| Sep 30, 2025 | 9.56 Bn |
| Jun 30, 2025 | 9.18 Bn |
| Mar 31, 2025 | 8.15 Bn |
| Dec 31, 2024 | 9.09 Bn |
| Sep 30, 2024 | 8.50 Bn |
| Jun 30, 2024 | 8.39 Bn |
| Mar 31, 2024 | 7.45 Bn |
| Dec 31, 2023 | 8.20 Bn |
| Sep 30, 2023 | 6.90 Bn |
| Jun 30, 2023 | 6.99 Bn |
| Mar 31, 2023 | 6.11 Bn |
| Dec 31, 2022 | 459.00 Mn |
| Sep 30, 2022 | 6.65 Bn |
| Jun 30, 2022 | 6.59 Bn |
| Mar 31, 2022 | 6.24 Bn |
| Dec 31, 2021 | 6.85 Bn |
| Sep 30, 2021 | 6.71 Bn |